Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GeneCure SARS vaccine
- Development stage
- Preclinical
- Lead developer
- GeneCure Biotechnologies
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
GeneCure SARS vaccine is an experimental viral vector vaccine candidate developed by GeneCure Biotechnologies for the prevention of Severe Acute Respiratory Syndrome (SARS). It utilizes the company's proprietary SimVec platform, which is based on a non-integrating lentiviral vector system. This technology is designed to efficiently deliver genetic material encoding SARS coronavirus antigens to host cells, thereby eliciting both humoral (antibody) and cellular (T-cell) immune responses. By using a non-integrating vector, the platform aims to provide the high transduction efficiency characteristic of lentiviruses while minimizing the risk of insertional mutagenesis, which is a concern with traditional integrating lentiviral systems.
- Other names
- SARS vaccineSimVec SARS vaccine
Beyond the preview
Go deeper on GeneCure SARS vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GeneCure SARS vaccine.